Traders Rotate Out of Biotech after Month Long Rally (XBI) (INCY) (REGN)
Tweet Send to a FriendGet Alerts INCY Hot Sheet
Up)
Trade INCY Now!
Shares of Incyte Genomics, Inc. (Nasdaq: INCY) are trading lower by 6 percent today. Incyte Corporation, a biopharmaceutical company, focuses the development and commercialization of proprietary small molecule drugs for oncology.
Shares of Incyte are up 61.5 percent year-to-date, and considering low volumes, traders say the selloff is tied to profit taking in biotech stocks today.
Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) are also trading lower. SPDR S&P Biotech, (NYSE: XBI) which owns both of these high fliers, is lower by 2.4 percent. XBI is up 14.3 percent in the past 30 days.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares of Incyte are up 61.5 percent year-to-date, and considering low volumes, traders say the selloff is tied to profit taking in biotech stocks today.
Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) are also trading lower. SPDR S&P Biotech, (NYSE: XBI) which owns both of these high fliers, is lower by 2.4 percent. XBI is up 14.3 percent in the past 30 days.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- GLD Holdings Continue to Decline (GLD) (SLV) (GDX)
- Gold Sinks Below $1400/oz (GLD) (IAU) (SLV)
- Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
Create E-mail Alert Related Categories
ETFsRelated Entities
Standard & Poor's
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
